Pre-exposure prophylaxis (PrEP) and medications for opioid use disorder for persons who inject drugs: the CHORUS + randomized controlled trial study protocol

Abstract Background Human immunodeficiency virus (HIV) cases among people who inject drugs increased during the US overdose crisis. Although HIV pre-exposure prophylaxis (PrEP) decreases HIV acquisition, and medications for opioid use disorder (MOUD) reduce overdose deaths, uptake remains suboptimal...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sarah E. Miller, Kimberly A. Dukes, Carolyn Damato-MacPherson, Christina Psaros, Nancy A. Scott, Jessica L. Taylor, Jordana Muroff, Michael R. Winter, Lisette E. Skiba, Hansel Lugo, Ricardo Cruz, Glorimar Ruiz-Mercado, Natalie D. Crawford, Kenneth H. Mayer, Sabrina A. Assoumou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-12-01
coleção:	Addiction Science & Clinical Practice
Assuntos:	Human immunodeficiency virus (HIV) Medications for opioid use disorder (MOUD) Pre-exposure prophylaxis (PrEP) Peer recovery coaching (PRC) Motivational interviewing (MI) HIV self-testing
Acesso em linha:	https://doi.org/10.1186/s13722-025-00634-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!